SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-18-000030
Filing Date
2018-05-09
Accepted
2018-05-09 16:09:00
Documents
20
Period of Report
2018-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-201805098xkdoc.htm 8-K 34558
2 PRESS RELEASE pdli-201805098xkex991.htm EX-99.1 148564
3 PRESENTATION pdli-201805098xkex992.htm EX-99.2 7223
4 INFORMATION SHEET pdli-201805098xkex993.htm EX-99.3 184543
5 pdllogo.jpg GRAPHIC 123123
6 slide1a64.jpg GRAPHIC 45638
7 slide2a64.jpg GRAPHIC 216640
8 slide3a64.jpg GRAPHIC 139462
9 slide4a64.jpg GRAPHIC 103190
10 slide5a64.jpg GRAPHIC 150862
11 slide6a64.jpg GRAPHIC 81172
12 slide7a64.jpg GRAPHIC 140676
13 slide8a62.jpg GRAPHIC 90911
14 slide9a61.jpg GRAPHIC 120361
15 slidq27.jpg GRAPHIC 98680
16 slidq28.jpg GRAPHIC 107528
17 slidq29.jpg GRAPHIC 139415
18 slidq30.jpg GRAPHIC 117166
19 slidq31.jpg GRAPHIC 101423
20 slidq32.jpg GRAPHIC 33321
  Complete submission text file 0000882104-18-000030.txt   2869489
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 18818317
SIC: 2836 Biological Products, (No Diagnostic Substances)